GSK Contract Manufacturing offers a fully integrated supply chain to support your projects at every level:  from early stage research and development, to clinical supply, to launch and growth of small, medium, and large-volume products.
We have state-of-the-art facilities for the manufacture of bulk biopharmaceutical products as well as fill-finish capabilities

• API - traditional small molecule, micronization, co-located R&D pilot plants
• steriles - lyophilization, syringes, vials, ampoules
• solid dose: immediate, controlled, and extended release tablets and capsules,
  bi-layer and tri-layer tablets, DiffCORE® technology, high containment
• cephalosporins and penicillins: solid dose, oral liquids, vials
• liquids, creams, and ointments: Liquid Dispensing Technology (LDT)
• respiratory dose forms: metered dose and dry powder inhalers

Giving you an advantage

With our highly professional staff, experienced in cGMP manufacturing, we can provide all the advantages you need for a successful contract manufacturing partnership, including:

• supply to over 150 countries worldwide
• facilities approved by US, EU, Japan, and international regulatory agencies
• technical expertise and resources
• development and new product introduction in conjunction with GSK R&D
• highly developed and proven methods for technology transfer
• a commitment to quality, safety, and sustainability
• experience in developing complex, difficult to produce products
• cost-effective supply solutions
• expertise in lean manufacturing processes
• a corporate global support network
• large company strength and small company flexibility
• scalable process capability
• a proven record in contract manufacturing and packaging